Mehmet Kemal Samur

Biography

Publications

• Development of hyperdiploidy starts at an early age and takes a decade to complete.

  Samur MK, Aktas Samur A, Shah P, Park J, Fulciniti M, Shammas MA, Corre J, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC. Blood 2024 Nov 21

• Correction: BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.

  Kurata K, Samur MK, Liow P, Wen K, Yamamoto L, Liu J, Morelli E, Gulla A, Tai YT, Qi J, Hideshima T, Anderson KC. Clin Cancer Res 2024 Sep 03

• Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies.

  Deng S, Derebail S, Weiler VJ, Fong Ng J, Maroto-Martin E, Chatterjee M, Giorgetti G, Chakraborty C, Kalhotra P, Du T, Yao Y, Prabhala R, Shammas M, Gulla A, Aktas Samur A, Samur MK, Qiu L, Anderson KC, Fulciniti M, Munshi NC. Blood Adv 2024 08 13

• RAS/RAF landscape in monoclonal plasma cell conditions.

  Schavgoulidze A, Corre J, Samur MK, Mazzotti C, Pavageau L, Perrot A, Cazaubiel T, Leleu X, Macro M, Belhadj K, Roussel M, Brechignac S, Montes L, Caillot D, Frenzel L, Rey P, Schiano de Colella JM, Chalopin T, Jacquet C, Richez V, Orsini-Piocelle F, Fontan J, Manier S, Martinet L, Sciambi A, Mohty M, Avet-Loiseau H. Blood 2024 07 11

• Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.

  Gulla A, Morelli E, Johnstone M, Turi M, Samur MK, Botta C, Cifric S, Folino P, Vinaixa D, Barello F, Clericuzio C, Favasuli VK, Maisano D, Talluri S, Prabhala R, Bianchi G, Fulciniti M, Wen K, Kurata K, Liu J, Penailillo J, Bragoni A, Sapino A, Richardson PG, Chauhan D, Carrasco RD, Hideshima T, Munshi NC, Anderson KC. Blood 2024 06 20